Kartos Therapeutics, Inc. is a company that provides Myelofibrosis, Merkel cell carcinoma, Oncology drugs and more. Kartos Therapeutics, Inc. is headquartered in United States California. Kartos Therapeutics, Inc. was founded in 2018. Kartos Therapeutics, Inc. has a total of 44 patents and 7 literature
What kind of company is Kartos Therapeutics, Inc.?
Kartos Therapeutics, Inc. is a company headquartered in Redwood City, CA, that operates as clinical stage biopharmaceutical company. The firm was founded...
What is Kartos Therapeutics, Inc.'s official website?